Rwanda vs South-Eastern Asia: Proportion of the target population who received 3 doses of
Rwanda
98.0%
in 2024
South-Eastern Asia
80.0%
in 2024
Rwanda rank
23rd
South-Eastern Asia rank
22nd
Proportion of the target population who received 3 doses of over time
- Rwanda
- South-Eastern Asia
How they compare
Rwanda currently reports 98.0% against 80.0% in South-Eastern Asia, a difference of 18.0%.
That makes Rwanda's figure about 1.2 times South-Eastern Asia's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Rwanda ahead.
Rwanda ranks 23rd and South-Eastern Asia ranks 22nd of 209 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.5% | 81.7% | 10.8% | Rwanda |
| 2010s | 97.7% | 87.2% | 10.5% | Rwanda |
| 2020s | 93.8% | 80.6% | 13.2% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received 3 doses of, Rwanda or South-Eastern Asia?
- Rwanda, at 98.0% against 80.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received 3 doses of between Rwanda and South-Eastern Asia?
- 18.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and South-Eastern Asia?
- 25 years are reported by both, from 2000 to 2024.
- How do Rwanda and South-Eastern Asia rank globally for proportion of the target population who received 3 doses of?
- Rwanda ranks 23rd and South-Eastern Asia ranks 22nd of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.